Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-055280
Filing Date
2021-09-09
Accepted
2021-09-09 16:23:40
Documents
2
Period of Report
2021-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3885
2 POA DOCUMENT poa.txt EX-24.4_1007653 3313
  Complete submission text file 0001209191-21-055280.txt   8539
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Whiting Nancy (Reporting) CIK: 0001880609 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 211244664